Answers are grounded in this paper and cite their sources.
Observational study reports reduced lymph node-to-muscle contrast ratios in MRN, suggesting improved visualization for surgical planning.
Motivation: Ferumoxytol provides vascular suppression in magnetic resonance neurography (MRN), but its effectiveness for lymph node suppression in MRN has not been quantified. Goal(s): To determine the optimal time and extent of lymph suppression achievable with a low-dose Ferumoxytol infusion for MRN. Approach: Two healthy subjects were imaged over a 50-hour post-infusion interval to determine the optimal time for MRN. Eight subjects were imaged to quantify lymph node suppression at the optimal time. Results: Immediately post-infusion (<1 hour), no significant differences were observed between nerve-to-muscle and lymph node-to-muscle contrast ratios. However, at the optimal 15 hours post-infusion, lymph node-to-muscle contrast ratios were significantly reduced. Impact: Low-dose Ferumoxytol provides significant lymph node suppression and simultaneous vascular suppression in brachial plexus magnetic resonance neurography (MRN) 15 hours post-infusion. Lymph suppression may enable 3D rendering to improve nerve visualization in diagnostic and surgical planning applications.
No takes yet. Share an insight, caveat, or question.
Turbin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: